BAY1021189
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BAY1021189, covering 2021-02-12 to 2021-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED) [Phase 2]